CATXPerspective Therapeutics, Inc.

$2.71-22% 1Y

$2.71

$2.0552 weeks$5.65

The financials

Perspective Therapeutics, Inc. by the numbers

The next results filing is expected around Nov 9, 2026, the same week as a year ago.

Perspective Therapeutics, Inc. income statement, Q2 2027 against the same quarter a year earlier
Income statement	Q2 2027	Q2 2026	Change
Operating income	−$29M	−$24M	n/a
Net income	−$27M	−$21M	n/a
Diluted EPS	−$0.22	−$0.29	n/a

Medical Devices

Ranks #46 of 51 by RyuScore

ClearPoint Neuro, Inc.

CapsoVision, Inc

VIEMED HEALTHCARE, INC.

Orthofix Medical Inc.

AVITA Medical, Inc.